Sector Update: Health Care Stocks Gain Wednesday Afternoon

MT Newswires Live

Jul 24, 2025

Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 2.2% and the Health Care Select Sector SPDR Fund (XLV) adding 1.8%.

The iShares Biotechnology ETF (IBB) climbed 1.6%.

In corporate news, Thermo Fisher Scientific (TMO) raised its full-year guidance as Q2 results surpassed Wall Street's estimates, and the company named a new chief financial officer. The shares jumped past 11%.

Boston Scientific (BSX) lifted its full-year outlook on Wednesday as it reported better-than-expected Q2 results, driven by 27% revenue growth in the cardiovascular segment. Its shares added 3.9%.

Dr. Reddy's Laboratories (RDY) is planning to launch a cheaper version of Novo Nordisk's (NVO) weight-loss drug Wegovy in 87 countries next year, Reuters reported, citing Chief Executive Erez Israeli's speech at a press conference. Dr. Reddy's shares rose more than 1%, and Novo was up over 5% in recent trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2553242154"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553242154\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553242154?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-24 01:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553242154","market":"us","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Gain Wednesday Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks rose Wednesday afternoon, with the <a href=\"https://laohu8.com/S/NYSE\">NYSE</a> Health Care Index up 2.2% and the <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) adding 1.8%.</p><p>The <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB) climbed 1.6%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/TMO\">Thermo Fisher Scientific</a> (TMO) raised its full-year guidance as Q2 results surpassed Wall Street's estimates, and the company named a new chief financial officer. The shares jumped past 11%.</p><p><a href=\"https://laohu8.com/S/BSX\">Boston Scientific</a> (BSX) lifted its full-year outlook on Wednesday as it reported better-than-expected Q2 results, driven by 27% revenue growth in the cardiovascular segment. Its shares added 3.9%.</p><p>Dr. Reddy's Laboratories (RDY) is planning to launch a cheaper version of <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s (NVO) weight-loss drug Wegovy in 87 countries next year, Reuters reported, citing Chief Executive Erez Israeli's speech at a press conference. Dr. Reddy's shares rose more than 1%, and Novo was up over 5% in recent trading.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Gain Wednesday Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Gain Wednesday Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-24 01:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks rose Wednesday afternoon, with the <a href=\"https://laohu8.com/S/NYSE\">NYSE</a> Health Care Index up 2.2% and the <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) adding 1.8%.</p><p>The <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB) climbed 1.6%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/TMO\">Thermo Fisher Scientific</a> (TMO) raised its full-year guidance as Q2 results surpassed Wall Street's estimates, and the company named a new chief financial officer. The shares jumped past 11%.</p><p><a href=\"https://laohu8.com/S/BSX\">Boston Scientific</a> (BSX) lifted its full-year outlook on Wednesday as it reported better-than-expected Q2 results, driven by 27% revenue growth in the cardiovascular segment. Its shares added 3.9%.</p><p>Dr. Reddy's Laboratories (RDY) is planning to launch a cheaper version of <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s (NVO) weight-loss drug Wegovy in 87 countries next year, Reuters reported, citing Chief Executive Erez Israeli's speech at a press conference. Dr. Reddy's shares rose more than 1%, and Novo was up over 5% in recent trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1291159041.SGD","symbol_name":"CPR Invest - Global Silver Age A2 Acc SGD-H","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2553242154","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553242154","pubTimestamp":1753293586,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 2.2% and the Health Care Select Sector SPDR Fund  adding 1.8%.The iShares Biotechnology ETF  climbed 1.6%.In corporate news, Thermo Fisher Scientific  raised its full-year guidance as Q2 results surpassed Wall Street's estimates, and the company named a new chief financial officer. The shares jumped past 11%.Boston Scientific  lifted its full-year outlook on Wednesday as it reported better-than-expected Q2 results, driven by 27% revenue growth in the cardiovascular segment. Its shares added 3.9%.Dr. Reddy's Laboratories  is planning to launch a cheaper version of Novo Nordisk's  weight-loss drug Wegovy in 87 countries next year, Reuters reported, citing Chief Executive Erez Israeli's speech at a press conference. Dr. Reddy's shares rose more than 1%, and Novo was up over 5% in recent trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4566":"资本集团","BSX":"波士顿科学","LU0251132253.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) ACC","LU2063271972.USD":"富兰克林创新领域基金","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","BK4535":"淡马锡持仓","RDY.AU":"READYTECH HOLDINGS LTD","LU2764263203.CNY":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (CNYHDG) ACC","BSX.AU":"BLACKSTONE MINERALS LTD","TMO":"赛默飞世尔","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC","LU1923621640.USD":"Natixis Thematics Water R/A USD","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","NVO.AU":"NOVO RESOURCES CORP-CDI","RDY":"如瑞迪博士","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","BK4548":"巴美列捷福持仓","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0557290698.USD":"施罗德环球可持续增长基金","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","XLV":"健康照护类股ETF-SPDR","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU0096362180.USD":"CT (LUX) I GLOBAL FOCUS \"DU\" (USD)","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU0342679015.USD":"ALLIANZ GLOBAL EQUITY UNCONSTRAINED \"AT\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","BK4599":"减肥药","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","IBB":"生物科技指数ETF-iShares Nasdaq","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU1923622291.USD":"Natixis Thematics Safety R/A USD","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H"},"translate_title":"行业更新：医疗保健股周三下午上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO.AU":1,"RDY":0.9,"BSX.AU":1,"RDY.AU":1,"XLV":1,"TMO":0.9,"IBB":1,"BSX":0.9},"content_text":"Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 2.2% and the Health Care Select Sector SPDR Fund (XLV) adding 1.8%.The iShares Biotechnology ETF (IBB) climbed 1.6%.In corporate news, Thermo Fisher Scientific (TMO) raised its full-year guidance as Q2 results surpassed Wall Street's estimates, and the company named a new chief financial officer. The shares jumped past 11%.Boston Scientific (BSX) lifted its full-year outlook on Wednesday as it reported better-than-expected Q2 results, driven by 27% revenue growth in the cardiovascular segment. Its shares added 3.9%.Dr. Reddy's Laboratories (RDY) is planning to launch a cheaper version of Novo Nordisk's (NVO) weight-loss drug Wegovy in 87 countries next year, Reuters reported, citing Chief Executive Erez Israeli's speech at a press conference. Dr. Reddy's shares rose more than 1%, and Novo was up over 5% in recent trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}